Editas Medicine Inc
NASDAQ:EDIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Editas Medicine Inc
NASDAQ:EDIT
|
US |
|
SUI Group Holdings Ltd
NASDAQ:SUIG
|
US |
|
Tethys Petroleum Ltd
XTSX:TPL
|
GG |
|
Namoi Cotton Ltd
ASX:NAM
|
AU |
|
Abivax SA
NASDAQ:ABVX
|
FR |
|
C
|
Comcast Corp
XMUN:CTP2
|
US |
|
C
|
CapitaLand Integrated Commercial Trust
XMUN:M3T
|
SG |
|
L
|
Landore Resources Ltd
LSE:LND
|
CA |
|
ForFarmers NV
F:5FF
|
NL |
|
Famous Brands Ltd
OTC:FMBRY
|
ZA |
|
Fu Yu Corporation Ltd
SGX:F13
|
SG |
|
M
|
Maxim Power Corp
OTC:MXGFF
|
CA |
|
C
|
Canadian Tire Corporation Ltd
XMUN:YAAA
|
CA |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
Interface Inc
NASDAQ:TILE
|
US |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
|
Cassius Mining Ltd
ASX:CMD
|
AU |
|
Liberty Defense Holdings Ltd
XTSX:SCAN
|
CA |
|
R
|
Remote Dynamics Inc
OTC:RMTD
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
Bankruptcy Probability
Editas Medicine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Editas Medicine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Editas Medicine Inc
NASDAQ:EDIT
|
472.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Editas Medicine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Editas Medicine Inc has total debt of 48.2m USD. This includes both short-term (0 USD) and long-term (48.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
